Q Biomed Inc (QBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23 | 50 | 138 | 27 | 137 |
| Receivables | N/A | 12 | 12 | 74 | 28 |
| Inventories | N/A | N/A | 23 | 22 | N/A |
| TOTAL | $34 | $72 | $186 | $145 | $201 |
| Non-Current Assets | |||||
| Investments And Advances | 3,143 | 3,143 | 0 | 0 | 0 |
| Intangibles | 288 | 300 | 313 | 325 | 338 |
| TOTAL | $3,431 | $3,443 | $313 | $325 | $338 |
| Total Assets | $3,465 | $3,516 | $498 | $470 | $538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,083 | 4,110 | 3,773 | 3,415 | 3,346 |
| Accounts payable and accrued liabilities | 2,253 | 2,132 | 2,301 | 1,952 | 1,805 |
| Accrued Expenses | 3,479 | 1,800 | 1,419 | 1,420 | 1,217 |
| Other current liabilities | 91 | 91 | 240 | 774 | N/A |
| TOTAL | $9,906 | $8,133 | $7,732 | $7,561 | $6,368 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,906 | $8,133 | $7,732 | $7,561 | $6,368 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,095 | 144,095 | 70,318 | 41,250 | 31,427 |
| Common Shares | 133 | 84 | 57 | 39 | 31 |
| Retained earnings | -68,317 | -66,096 | -68,398 | -67,603 | -66,332 |
| Other shareholders' equity | 5,190 | 5,086 | 5,255 | 5,526 | 6,074 |
| TOTAL | $-6,441 | $-4,617 | $-7,234 | $-7,091 | $-5,830 |
| Total Liabilities And Equity | $3,465 | $3,516 | $498 | $470 | $539 |